Articles about Novavax

Serum gets nod for Novavax trial in 7-11 age group

29 Sep 2021

India
Serum gets nod for Novavax trial in 7-11 age group

The Serum Institute of India (SII) has received the approval to conduct trials of the Novavax COVID-19 vaccine in children aged between seven and 11 years.

Novavax seeks 'OK' for COVID-19 vaccine in needy countries first

06 Aug 2021

World
Novavax seeks 'OK' for COVID-19 vaccine in needy countries first

Vaccine maker Novavax announced Thursday that it has asked regulators in India, Indonesia, and the Philippines to allow emergency use of its COVID-19 vaccine—offering its shot to some low-income countries before rich ones with ample supplies.

Expert panel says no to Covovax's children trials in India

01 Jul 2021

India
Expert panel says no to Covovax's children trials in India

A Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) has denied permission to Pune-based Serum Institute of India (SII) for conducting clinical trials of its second COVID-19 vaccine, Covovax, in children.

Serum to begin Covovax trials on children in July

26 Jun 2021

India
Serum to begin Covovax trials on children in July

The Serum Institute of India (SII) will soon apply for regulatory approval to conduct clinical trials of Covovax on children in India.

How Biological E's coronavirus vaccine could be a potential gamechanger

17 Jun 2021

India
How Biological E's coronavirus vaccine could be a potential gamechanger

A made-in-India coronavirus vaccine being developed by the Hyderabad-based firm Biological E is expected to be up to 90% effective against COVID-19, an expert from a government advisory panel said.

Covovax India launch by September; trial for kids soon: SII

17 Jun 2021

India
Covovax India launch by September; trial for kids soon: SII

The Serum Institute of India (SII) is looking to launch the COVID-19 vaccine developed by the United States firm Novavax in India by September.

Novavax's COVID-19 vaccine is over 90% effective, firm says

14 Jun 2021

India
Novavax's COVID-19 vaccine is over 90% effective, firm says

American firm Novavax's coronavirus vaccine has been found safe and over 90% effective, including against some variants, the company announced on Monday.

Serum CEO Poonawalla hopes to launch second vaccine by September

27 Mar 2021

India
Serum CEO Poonawalla hopes to launch second vaccine by September

Serum Institute of India CEO Adar Poonawalla today said that his company hopes to launch its second coronavirus vaccine by September this year.

COVID-19 vaccines: SII to play huge role in mass production

25 Feb 2021

World
COVID-19 vaccines: SII to play huge role in mass production

British-Swedish pharmaceutical giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.

Novavax vaccine seems effective against COVID-19 in UK study

29 Jan 2021

Technology
Novavax vaccine seems effective against COVID-19 in UK study

Novavax Inc. said on Thursday that its COVID-19 vaccine appears 89 percent effective based on early findings from a British study.

India to get 10cr COVID-19 vaccine doses by December: SII

14 Nov 2020

Technology
India to get 10cr COVID-19 vaccine doses by December: SII

The Serum Institute of India is hoping to produce 100 million (10 crore) doses of AstraZeneca and Oxford University's COVID-19 vaccine, CEO Adar Poonawalla said.

Coronavirus: Bharat Biotech aims to launch COVAXIN by June 2021

24 Oct 2020

India
Coronavirus: Bharat Biotech aims to launch COVAXIN by June 2021

Hyderabad-based pharmaceutical firm Bharat Biotech is expecting to launch its coronavirus vaccine candidate, COVAXIN, by June next year.

PM's vaccine arrangements will take care of all: Adar Poonawalla

27 Sep 2020

India
PM's vaccine arrangements will take care of all: Adar Poonawalla

As India's COVID-19 vaccine strategy becomes a point of debate, Adar Poonawalla has expressed confidence over Prime Minister Narendra Modi's vision to protect Indian citizens from the ongoing pandemic.

NewsBytes Briefing: Amazon announces ball-shaped Echo products, and more

25 Sep 2020

Technology
NewsBytes Briefing: Amazon announces ball-shaped Echo products, and more

Last night, Amazon made major headlines by showcasing plenty of products.

Coronavirus vaccine won't be available for all before 2024-end: Poonawalla

14 Sep 2020

India
Coronavirus vaccine won't be available for all before 2024-end: Poonawalla

Adar Poonawalla, the CEO of the Serum Institute of India (SII), that has taken up the mammoth task of mass-producing the vaccine for novel coronavirus, asserted that the vaccine will not be available for the entire world before the end of 2024.

Novavax's COVID-19 vaccine goes into mid-stage human trials: Details here

17 Aug 2020

World
Novavax's COVID-19 vaccine goes into mid-stage human trials: Details here

As the number of COVID-19 cases continues to explode around the world, drug companies from different companies are racing to get a safe preventive vaccine ready.

Three indigenous coronavirus vaccines in trials, distribution plan ready: PM

15 Aug 2020

India
Three indigenous coronavirus vaccines in trials, distribution plan ready: PM

With the world counting on a coronavirus vaccine to save it from the disease that has taken 763,572 lives so far, Prime Minister Narendra Modi on Saturday said India is ready to mass-produce the vaccine once it's developed.

India likely to have COVID-19 vaccine by December: Adar Poonawalla

11 Aug 2020

India
India likely to have COVID-19 vaccine by December: Adar Poonawalla

India should have a vaccine to exit the COVID-19 pandemic by the end of this year.

Serum Institute's COVID-19 vaccines will come at $3 per dose

07 Aug 2020

India
Serum Institute's COVID-19 vaccines will come at $3 per dose

In a major development, the Serum Institute of India has confirmed that the price of its foreign-licensed COVID-19 vaccines will be capped at $3 per dose in low-to-middle-income nations.

India's Serum Institute signs COVID-19 vaccine deal with America's Novavax

06 Aug 2020

Business
India's Serum Institute signs COVID-19 vaccine deal with America's Novavax

Serum Institute of India (SII) is set to source the COVID-19 vaccine developed by American biotech company Novavax.

NewsBytes Briefing: Facebook, Twitter remove Trump's misleading post, and more

06 Aug 2020

Technology
NewsBytes Briefing: Facebook, Twitter remove Trump's misleading post, and more

In the updates since last night, both Facebook and Twitter launched a crackdown on a misleading post from US President Donald Trump.

COVID-19 vaccine: What are the latest updates?

21 Jun 2020

Technology
COVID-19 vaccine: What are the latest updates?

As COVID-19 continues to wreak havoc around the world, the entire scientific community is progressing forward with the efforts to develop a vaccine that could finally end the pandemic.

China's Sinovac gets positive results in COVID-19 vaccine trials

15 Jun 2020

Technology
China's Sinovac gets positive results in COVID-19 vaccine trials

China's Sinovac Biotech has announced "positive" results from the clinical trials of its experimental COVID-19 vaccine.

COVID-19 vaccine: What are the latest updates?

07 Jun 2020

Technology
COVID-19 vaccine: What are the latest updates?

With a sporadic increase in the number of cases and deaths, COVID-19 is growing beyond control in India.

New COVID-19 vaccine goes into human trials: Details here

26 May 2020

Technology
New COVID-19 vaccine goes into human trials: Details here

As COVID-19 continues to batter different parts of the world, scientists are racing to find a way to fight the pandemic as soon as possible.

Bhopal: Doctors claim homeopathy cured coronavirus patients, experts unhappy

26 May 2020

India
Bhopal: Doctors claim homeopathy cured coronavirus patients, experts unhappy

At a time when the world is scrambling to produce a vaccine for coronavirus, a state-run homeopathy hospital in Bhopal, Madhya Pradesh, claimed it has treated six patients, drawing fire from health experts.